Italia markets closed

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
1,6305-0,0195 (-1,18%)
Al 02:11PM EDT. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente1,6500
Aperto1,6200
Denaro1,6300 x 3100
Lettera1,6400 x 34100
Min-Max giorno1,6000 - 1,6900
Intervallo di 52 settimane1,1100 - 5,9700
Volume870.836
Media Volume3.779.358
Capitalizzazione657,427M
Beta (5 anni mensile)1,85
Rapporto PE (ttm)N/D
EPS (ttm)-0,0560
Prossima data utili03 ago 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A3,57
  • GlobeNewswire

    Latest Research Evaluating VASCEPA®/VAZKEPA (icosapent ethyl) and Subgroups from the REDUCE-IT® Landmark Outcomes Trial to be Presented at the European Society of Cardiology (ESC) Congress

    DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded research on the effects of VASCEPA®/VAZKEPA (icosapent ethyl) in specific patient subgroups at increased risk of a cardiovascular (CV) event from the landmark REDUCE-IT® cardiovascular outcomes trial have been accepted for presentation at the European Society of Cardiology (ESC) Congress, both online and onsite in Barcelona, August 26-29, 2022.

  • GlobeNewswire

    Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update

    Company Received Final Positive Reimbursement Decision for VAZKEPA® by UK’s NICE in England & Wales Market Access Negotiations and Launch Preparations for VAZKEPA Underway Across Multiple European Markets Initiated Comprehensive Cost Reduction Plan in June to Address Market Dynamics in the U.S. with Expected Savings of $100 Million Over 12 Months* Plans On Track for Regulatory Filings for Approval of VASCEPA® (icosapent ethyl) in Several Additional Countries in 2022 Company to Host Conference Ca

  • GlobeNewswire

    Amarin to Report Second Quarter 2022 Financial Results and Host Conference Call on August 3, 2022

    DUBLIN, Ireland and BRIDGEWATER, N.J., July 20, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin’s senior management team to discuss the Company’s second quarter 2022 financial results on Wednesday, August 3rd, 2022 at 8:00 a.m. ET. The conference call with management will follow the release of the Company’s second quarter 2022 financial results in the pre-market hours. Conference Call and Webcast Information